Simon Sturge, Director at MoonLake Immunotherapeutics (MLTX), sold 171,000 shares at $53.72 ($9.2M) on 2024-10-04, disclosed to the SEC on 2024-10-08.
Open-market sale of $9.2M MLTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.